TR199802647T2 - H+, K+-ATPaz inhibitörlerinin administrasyon rejimi. - Google Patents

H+, K+-ATPaz inhibitörlerinin administrasyon rejimi.

Info

Publication number
TR199802647T2
TR199802647T2 TR1998/02647T TR9802647T TR199802647T2 TR 199802647 T2 TR199802647 T2 TR 199802647T2 TR 1998/02647 T TR1998/02647 T TR 1998/02647T TR 9802647 T TR9802647 T TR 9802647T TR 199802647 T2 TR199802647 T2 TR 199802647T2
Authority
TR
Turkey
Prior art keywords
administration regimen
atpase inhibitors
extended
profile
extended plasma
Prior art date
Application number
TR1998/02647T
Other languages
English (en)
Inventor
Cederberg Christer
Sachs George
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of TR199802647T2 publication Critical patent/TR199802647T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Bir H+, K+-ATPaz inhibitörünün uzatilmis bir plazma konsantrasyon profilini veren yeni bir administrasyon rejimi. Uzatilmis plazma profili 0.5 ila 4 saatlik aralikla bir H+, K+-ATPazinin bir ünite dozunun birbirini takip eden iki veya daha fazla administrasyonu veya günde bir defa verilecek olan, uzatilmis saliverme kabiliyetini havi bir farmasötik kompozisyonun verilmesi sureti ile elde edilir.
TR1998/02647T 1996-06-20 1997-06-18 H+, K+-ATPaz inhibitörlerinin administrasyon rejimi. TR199802647T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9602442A SE9602442D0 (sv) 1996-06-20 1996-06-20 Administration of pharmaceuticals

Publications (1)

Publication Number Publication Date
TR199802647T2 true TR199802647T2 (tr) 1999-03-22

Family

ID=20403092

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/02647T TR199802647T2 (tr) 1996-06-20 1997-06-18 H+, K+-ATPaz inhibitörlerinin administrasyon rejimi.

Country Status (27)

Country Link
US (4) US20010008900A1 (tr)
EP (1) EP0921787B1 (tr)
JP (1) JP2000512993A (tr)
CN (1) CN1178648C (tr)
AT (1) ATE252885T1 (tr)
AU (1) AU726859B2 (tr)
BR (1) BR9709838A (tr)
CA (1) CA2257405A1 (tr)
CZ (1) CZ298213B6 (tr)
DE (1) DE69725860T2 (tr)
DK (1) DK0921787T3 (tr)
EE (1) EE04606B1 (tr)
ES (1) ES2208921T3 (tr)
HU (1) HUP9901794A3 (tr)
IL (2) IL127542A0 (tr)
IS (1) IS2216B (tr)
NO (1) NO323295B1 (tr)
NZ (1) NZ332990A (tr)
PL (1) PL189716B1 (tr)
PT (1) PT921787E (tr)
RS (1) RS49590B (tr)
RU (1) RU2203662C2 (tr)
SE (1) SE9602442D0 (tr)
SK (1) SK284204B6 (tr)
TR (1) TR199802647T2 (tr)
UA (1) UA64715C2 (tr)
WO (1) WO1997048380A1 (tr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
WO1999055158A1 (en) * 1998-04-30 1999-11-04 Sepracor Inc. S-rabeprazole compositions and methods
AU3870599A (en) * 1998-04-30 1999-11-16 Sepracor, Inc. R-rabeprazole compositions and methods
ES2192394T3 (es) 1998-08-10 2003-10-01 Winston Pharmateuticals Llc Profarmacos de inhibidores de la bomba de protones.
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
US7041313B1 (en) 1998-08-12 2006-05-09 Altana Pharma Ag Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US5330982A (en) * 1986-12-17 1994-07-19 Glaxo Group Limited Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
CA2161256C (en) * 1993-04-27 2004-06-29 Nancy M. Gray Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
DK1078628T3 (da) * 1994-07-08 2009-02-23 Astrazeneca Ab Tabletteret flerenhedsdoseringsform
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors

Also Published As

Publication number Publication date
EP0921787B1 (en) 2003-10-29
HK1018590A1 (en) 1999-12-30
US20070276007A1 (en) 2007-11-29
PL189716B1 (pl) 2005-09-30
WO1997048380A1 (en) 1997-12-24
US20090036494A1 (en) 2009-02-05
YU56698A (sh) 2004-12-31
DE69725860D1 (de) 2003-12-04
SE9602442D0 (sv) 1996-06-20
CZ420398A3 (cs) 2000-02-16
BR9709838A (pt) 1999-08-10
NO985964L (no) 1999-02-22
IL127542A0 (en) 1999-10-28
ATE252885T1 (de) 2003-11-15
NO985964D0 (no) 1998-12-18
HUP9901794A3 (en) 2002-11-28
PL330910A1 (en) 1999-06-07
EP0921787A1 (en) 1999-06-16
IL127542A (en) 2006-08-01
CN1178648C (zh) 2004-12-08
ES2208921T3 (es) 2004-06-16
PT921787E (pt) 2004-03-31
AU3469097A (en) 1998-01-07
US20050113418A1 (en) 2005-05-26
NO323295B1 (no) 2007-03-05
EE9800435A (et) 1999-06-15
IS4923A (is) 1998-12-15
DE69725860T2 (de) 2004-09-09
AU726859B2 (en) 2000-11-23
HUP9901794A2 (hu) 2000-04-28
UA64715C2 (en) 2004-03-15
SK165598A3 (en) 1999-08-06
NZ332990A (en) 2000-07-28
EE04606B1 (et) 2006-04-17
IS2216B (is) 2007-03-15
CN1222074A (zh) 1999-07-07
CZ298213B6 (cs) 2007-07-25
JP2000512993A (ja) 2000-10-03
CA2257405A1 (en) 1997-12-24
DK0921787T3 (da) 2004-02-23
SK284204B6 (sk) 2004-10-05
RU2203662C2 (ru) 2003-05-10
RS49590B (sr) 2007-06-04
US20010008900A1 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
TR200102962T2 (tr) Yeni tedavi metodu.
BRPI0417947A (pt) composto, composição farmacêutica, fabricação de um medicamento para o uso no tratamento e/ou prevenção de um metabólico distúrbio, e, formulação farmacêutica
SE9602442D0 (sv) Administration of pharmaceuticals
BR9914451A (pt) Composto de oxazol, processo para sua preparação, composição farmacêutica compreendendo dito composto, uso da composição e métodos de tratamento
HUP0100072A2 (hu) Fenoxazin-, fentiazinszármazékok, alkalmazásuk a gyógyászatban; előállításukra szolgáló eljárás és az ezeket tartalmazó gyógyszerészeti készítmények
FI951454A0 (fi) 1-(2-oksoasetyyli)piperidiini-2-karboksyylihappojohdannaiset monille lääkkeille resistenttien syöpäsolujen herkistäjinä
DE69532687D1 (de) Pharmazeutische zusammensetzungen zur vorbeugung und behandlung der ulzerativen kolitis
ATE315021T1 (de) Pharmazeutische verbindungen
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
PT1200426E (pt) Tieno-3-il-sulfonilamino (tio) carbonil-triazolino (ti) onas substituidas
TR200200416T2 (tr) İkame edilmiş fenilusikloheksil bileşimlerinden elde edilmiş yeni esterler.
KR960013370A (ko) 트리글리세리드 과다 방지 조성물
ATE322163T1 (de) Substituierte cyclopentanderivate die als neuramidase-inhibitoren nuetzlich sind
ATE45153T1 (de) Benzisoselenazolthione, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische produkte.
BR0012970A (pt) Compostos e composições antipicornavirais, seus usos farmacêuticos e materiais para a sua sìntese
ATE305473T1 (de) Pdgf-rezeptor-kinase hemmende verbindungen, deren herstellung, reinigung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
ATE183192T1 (de) Neue colon-oder ilean-spezifische steroid derivate
BR9916318A (pt) Compostos bicìclicos
BR0009701A (pt) Compostos ou sais, ou suas composições, uso dos mesmos, e, formulações farmacêuticas
ATE84026T1 (de) Spirotricycloaromatische succinimidderivate als aldose-reduktase-inhibitoren.
KR890014107A (ko) 백금 화학 요법약제
TR200101083T2 (tr) (7alfa,17alfa)-17-hidroksi- 7-metil-19-nor-17-pregn-5 (10)-en-20-in-3-on içeren yüksek saflıkta bileşim.
NO952900L (no) Materiale inneholdende tandospiron eller analoger derav
HUP0004590A2 (hu) Endotelin-antagonista imidazolszármazékokat és béta receptor blokkolókat tartalmazó kombinációs gyógyszerkészítmények
MX9700198A (es) Compuestos peptidos de proinsulina para detectar y tratar diabetes tipo 1.